Location History:
- Hyogo, JP (2021)
- Osaka, JP (2021)
Company Filing History:
Years Active: 2021-2025
Title: Shunji Ichio: Innovator in Pharmaceutical Formulations
Introduction
Shunji Ichio is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical formulations, holding a total of 4 patents. His work focuses on improving the stability and dissolution profiles of various compounds, which is crucial in the development of effective medications.
Latest Patents
Ichio's latest patents include innovative formulations that enhance the properties of morphinan derivatives. One of his notable inventions is a preparation containing 6,7-unsaturated-7-carbamoyl morphinan derivatives. This solid preparation improves the dissolution profile and stability of the compound. Specifically, when combined with croscarmellose sodium and ferric oxide, the dissolution rate after 15 minutes exceeds 85%, significantly enhancing light stability. Another patent details a manufacturing process for solid formulations that achieves improved content uniformity. This method ensures that the standard deviation of the active ingredient content is 5% or less by utilizing excipients with a median particle size significantly larger than that of the active ingredient.
Career Highlights
Shunji Ichio is associated with Shionogi Company Limited, a leading pharmaceutical company known for its commitment to innovation and quality. His work at Shionogi has allowed him to focus on developing advanced formulations that address critical challenges in drug delivery and efficacy.
Collaborations
Ichio has collaborated with notable colleagues, including Akira Mashimo and Yoshinori Tamura. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their innovations.
Conclusion
Shunji Ichio's contributions to pharmaceutical formulations exemplify the importance of innovation in the medical field. His patents reflect a commitment to improving drug stability and efficacy, which ultimately benefits patients worldwide.